Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Population pharmacokinetics study of imatinib in chronic myeloid leukemia
IRCT2014050612206N1Phase 4Completed
- Sponsor
- Kerman University of Medical Sciences
- Start
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of imatinib in chronic myelogenous leukemia (CML), sponsored by Kerman University of Medical Sciences. Started May 2014; status: completed.
02
Drugs
03
Conditions
chronic myelogenous leukemia (CML)
Beyond the preview
Go deeper on IRCT2014050612206N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT2014050612206N1.